Characterization of the Postconditioning Effect of Dexmedetomidine in Mouse Organotypic Hippocampal Slice Cultures Exposed to Oxygen and Glucose Deprivation
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 112 (2) , 373-383
Abstract
Background: There is an increasing interest in the use of dexmedetomidine for anesthesia and sedation. Here, we used the mouse organotypic hippocampal slice culture to investigate whether dexmedetomidine exhibits postconditioning properties against oxygen and glucose deprivation (OGD). The role of the focal adhesion and extracellular-regulated kinases pathways in these effects were examined in both postconditioning and preconditioning. Materials and Methods: Slices were obtained from P5 mouse. In postconditioning experiments, Dexmedetomidine (1 microm) was incubated 60 min after the end of OGD. In preconditioning experiments, dexmedetomidine was applied 3 h before OGD. Pharmacologic modulation of the studied pathways was achieved by using selective inhibitors of these cascades. Cell death was assessed 72 h after OGD using propidium iodide labeling and protein expression of activated caspase 3. Results: Maximum cell death increased with the duration of OGD. Dexmedetomidine induced a postconditioning effect in the CA1 (but not dentate gyrus) subfield area, which was significantly reduced by modulators of the focal adhesion and the extracellular-regulated kinases pathways. The combination of the inhibitors of the two pathways completely abolished the postconditioning effect of dexmedetomidine. The preconditioning effect of dexmedetomidine against ischemia-induced injury was observed in all hippocampal subfield areas. Results obtained with the pharmacologic modulation used for postconditioning also applied to dexmedetomidine-induced preconditioning. Discussion: Dexmedetomidine exhibits significant, but moderate, postconditioning properties against oxygen and glucose deprivation-induced injury. Activation of focal adhesion and the imidazoline 1 receptors-extracellular-regulated kinases pathways is involved in dexmedetomidine-induced postconditioning and preconditioning as well.Keywords
This publication has 39 references indexed in Scilit:
- Dexmedetomidine Attenuates Isoflurane-induced Neurocognitive Impairment in Neonatal RatsAnesthesiology, 2009
- Inhalational anesthetics as preconditioning agents in ischemic brainCurrent Opinion in Pharmacology, 2008
- Molecular Physiology of Preconditioning-Induced Brain Tolerance to IschemiaPhysiological Reviews, 2008
- Inhalational Anesthetics as Neuroprotectants or Chemical Preconditioning Agents in Ischemic BrainJournal of Cerebral Blood Flow & Metabolism, 2007
- Translational research in stroke: Taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trialsCurrent Neurology and Neuroscience Reports, 2007
- The Effects of Dexmedetomidine on Perinatal Excitotoxic Brain Injury are Mediated by the α2A-Adrenoceptor SubtypeAnesthesia & Analgesia, 2006
- Effects of Dexmedetomidine on Hippocampal Focal Adhesion Kinase Tyrosine Phosphorylation in Physiologic and Ischemic ConditionsAnesthesiology, 2005
- Dexmedetomidine produces its neuroprotective effect via the α2A-adrenoceptor subtypeEuropean Journal of Pharmacology, 2004
- Ischemic tolerance and endogenous neuroprotectionTrends in Neurosciences, 2003
- Effect of the α2-Agonist Dexmedetomidine on Cerebral Neurotransmitter Concentrations during Cerebral Ischemia in RatsAnesthesiology, 2002